Author:
Yuan Jinxia,Yan Fei,Li Wei,Yuan Guoliang
Abstract
Objective: Using a network pharmacological approach, this study will evaluate the effect of Xuefu Zhuyu Decoction in the treatment of atherosclerosis.Methods: The data were imported into the STRING database to construct a protein-protein interaction network, and the network topology was analysed with the Bisogenet plug-in by Cytoscape 3.7.2. Using the R language Bioconductor platform, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis for potential targets of Xuefu Zhuyu Decoction in the treatment of atherosclerosis were performed, and import the results were imported into Cytoscape 3.7.2. To map the results and create a KEGG network diagram, we used Cytoscape 3.7.2 for analysis.Results: A total of 91 chemical components and 1320 disease targets were obtained, including 138 cross-targets. TNF, AKT1 and ALB were identified as important targets, and Gene Ontology functional analysis indicated that biological process was the primary cause of oxidative stress. The primary action of molecular function is binding. KEGG has explored and enriched 149 signalling pathways, including the AGE-RAGE signalling system and the TNF signalling network. According to a study involving molecular docking, quercetin and β-carotene have a strong binding affinity for AKT1 and ALB.Conclusion: The potential of Xuefu Zhuyu Decoction to treat atherosclerosis through multiple components and targets provides a way to further study its mechanism.
Subject
Pharmacology (medical),Pharmacology
Reference21 articles.
1. Role of inflammatory cytokines in Genesis and treatment of atherosclerosis;Biros;Trends cardiovasc. Med.,2022
2. Clinical observation on the prevention of deep vein thrombosis after total hip arthroplasty with the application of hemifu huang yu tang;Cao;J. Pract. Chin. Med.,2022
3. MiR-155-5p inhibits the proliferation and migration of VSMCs and HUVECs in atherosclerosis by targeting AKT1;Chen;Eur. Rev. Med. Pharmacol. Sci.,2019
4. Emerging role of IL-17 in atherosclerosis;Chen;J. Innate Immun.,2010
5. IL-17: A promising therapeutic target for atherosclerosis;Fan;Int. J. Cardiol.,2016